Cynapsus Therapeutics Inc. : Announces Proposed Public

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cynapsus Therapeutics Inc. : Announces Proposed Public Offering in the United States, Listing on NASDAQ and Share Consolidation

TORONTO, May 15, 2015 (GLOBE NEWSWIRE) -- Cynapsus Therapeutics Inc. (TSX: CTH) (OTCQX: CYNAF) announced today the filing of a registration statement with the US Securities and Exchange Commission relating to a public offering in the United States of its common shares and the filing of an application to list on the NASDAQ Capital Market. The timing, number of shares and price per share of the proposed offering have not yet been determined. Cynapsus also announced an amendment to the Company's articles to consolidate the issued and outstanding common shares of the Company on the basis of one post-consolidation common share for 16 pre-consolidation common shares to facilitate the proposed listing on NASDAQ, as previously approved by the shareholders of the Company.

BofA Merrill Lynch is acting as sole book-running manager for the proposed offering, Nomura is acting as a lead manager and Noble Life Science Partners is acting as co-manager.

A registration statement relating to these securities has been filed with the Ontario Securities Commission and the Securities and Exchange Commission under the multijurisdictional disclosure system. The registration statement has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time that the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering will be made outside of Canada only by means of a prospectus. When available, copies of the preliminary prospectus relating to the offering may be obtained by investors, other than Canadian investors, by contacting BofA Merrill Lynch, 222 Broadway, New York, NY 10038, Attn: Prospectus Department, or via email, at dg.prospectus_requests@baml.com.  Any offering of the common shares in Canada will be made on a private placement basis in accordance with available prospectus exemptions.  

About Cynapsus

Cynapsus is a specialty central nervous system pharmaceutical company developing and preparing to commercialize a Phase 3, fast-acting, easy-to-use, sublingual thin film for the on-demand turning ON of debilitating OFF episodes associated with Parkinson's disease. 

Contact Information

Cynapsus Therapeutics

Anthony Giovinazzo

President and CEO

(416) 703-2449 x225

ajg@cynapsus.ca

Andrew Williams

COO & CFO

(416) 703-2449 x253

awilliams@cynapsus.ca

Forward-Looking Statements

This announcement contains "forward-looking statements" within the meaning of applicable securities laws, including with respect to the anticipated public offering and the listing of the common shares on NASDAQ Capital Market. These forward-looking statements include information about possible or assumed future results of our business, financial condition, results of operations, liquidity, plans and objectives. In some cases, you can identify forward-looking statements by terminology such as "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "expect," "predict," "potential," or the negative of these terms or other similar expressions.

The statements we make regarding the following matters are forward-looking by their nature and are based on certain of the assumptions: our beliefs regarding the advantages of APL-130277 and assumptions that others will share such beliefs; our expectations regarding the commercialization of APL-130277, including effectiveness of targeted sales efforts and the education of members of our target market such as doctors, patients and payors and our assumption that such persons will prescribe or use our product once they understand the benefits; our belief that the opportunity for APL-130277 outside the United States for PD patients is substantial; our beliefs regarding the main competitors for APL-130277; our belief that there is an unmet medical need and market opportunity for APL-130277; our expectations regarding regulatory approval in the United States and in other jurisdictions, including the indications approved for our label for APL-130277, and timing thereof; our expectation that APL-130277 will be able to follow the regulatory pathway set forth in Section 505(b)(2) of the FDCA; our plan to timely commence and/or complete remaining trials and studies as required by the FDA and other regulators, including our Phase 3 clinical trials and studies; our belief that the current manufacturing capabilities of our partners are sufficient to support the remaining clinical trial needs and commercial launch of our product candidate; our beliefs regarding frequency, types and severity of OFF episodes; our assumption that two-thirds of patients that suffer OFF episodes suffer at least one OFF episode per day; our expectations that our U.S. and foreign patents will not expire early or prematurely; our ability to successfully protect our intellectual property; our expectations regarding future capital needs and funding requirements and our assumption relating to current and future costs; and our ability to otherwise successfully develop APL-130277 and any other product candidates we may develop in the future; as well as the factors identified in our public filings.

Furthermore, unless otherwise stated, the forward-looking statements contained in this press release are made as of the date of this press release, and we have no intention and undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither the TSX nor the OTCQX International has approved or disapproved of the contents of this press release.

HUG#1921941

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lieda Shadwick’s Career Education Work Earns 2026 Honor

Updated Category News Views 66

Twenty-six years in classrooms is not the sort of accomplishment that needs fireworks to carry weight. Lieda A. Shadwick’s recognition as The Inner Circle’s 2026 Educator of the Year points to a career built around a stubbornly important idea: students need more than academic vocabulary if they are going to navigate work, leadership, and business with any confidence....

Continue Reading
Five SEAL Medal of Honor Signatures, One Charity Lot

Updated Category News Views 58

A single rifle can carry a staggering amount of meaning when the names on it belong to all five living U.S. Navy SEAL Medal of Honor recipients. Rock Island Auction Company plans to offer that one-of-a-kind custom precision rifle during its December 4–6, 2026 Premier Firearms Auction, and the financial arrangement is unusually clean: 100% of proceeds are slated for the...

Continue Reading
AI Forces Learning Teams to Redefine Their Core Job

Updated Category News Views 73

Training Departments Are Not Sitting Still Corporate learning has spent years being treated like the office instruction manual, and AI is making that old arrangement look awfully flimsy. RedThread Research's November 19, 2026 study lands on a point that ought to make senior management pay attention: learning and development leaders are not merely waiting around to be...

Continue Reading
Botanica’s Illuminations Carries More Than Holiday Glow

Updated Category News Views 74

Two million lights are doing more than brightening up a few winter evenings in Wichita. Illuminations at Botanica returns from November 23, 2026, through January 2, 2027, and the pleasant part of this story is that the spectacle has a practical backbone: it is Botanica’s largest fundraiser. For a garden nonprofit, that matters a whole lot more than another shiny...

Continue Reading
Movement Elevates a Longtime Insider as Its New CEO

Updated Category News Views 81

Chalk dust rarely makes headlines, yet this is the sort of leadership change that can decide whether a consumer brand keeps its footing. Movement Climbing, Yoga and Fitness named Ryan Sewell chief executive officer effective November 18, 2026, with Anne-Worley Moelter moving into the chairperson role. It is a conspicuously internal handoff: Sewell started at the Boulder...

Continue Reading
LKQ’s Europe ERP Mess Turns Into a Credibility Test

Updated Category News Views 80

A software rollout should not be able to punch a company in the teeth twice, yet LKQ shareholders have watched precisely that ugly movie in 2026. The October 23 disclosure was a real gut-check: an immediate CEO departure, a $16 million net loss, and renewed acknowledgement that the German enterprise-resource-planning rollout was disrupting Europe. Shares fell $5.05, or...

Continue Reading
Nvidia Faces SEC Probe Report and New Lawsuit Stakes

Updated Category News Views 187

Silicon Valley's favorite growth machine has stumbled into the sort of fog investors hate most: regulatory questions, leadership upheaval, and a stock-price reaction with no clean answer attached. Reports cited in the lawsuit update say the Securities and Exchange Commission has opened a civil probe into NVIDIA's investor disclosures following former CEO Jensen Huang's...

Continue Reading
Live Nation Tests Creator Content With Morgan Jay Series

Updated Category News Views 135

A comedian turning crowd work into songs is hardly a boardroom event, but this one has a useful wrinkle: Live Nation Studios put financing behind it. Morgan Jay and Austin-based agency Hello Party launched Music Therapy with Morgan Jay on YouTube on November 18, with Kam Patterson opening the season. The show pairs Jay and celebrity guests for loose conversation,...

Continue Reading
NYSE Message Record Puts Market Plumbing Into Focus

Updated Category News Views 120

A trillion messages is not a cute little exchange statistic; it is the sort of number that tells you whether the market’s pipes can keep working when everybody starts shouting at once. NYSE says it handled a record 1.166 trillion messages in one day on November 5, roughly 4% above the prior high set amid April 2025 volatility. Better yet, according to the exchange,...

Continue Reading
First Grade Literacy Push Deserves a Harder Look Now

Updated Category News Views 138

A reading gap can become a concrete wall before anyone bothers measuring it. That is the uncomfortable point behind Ignite Reading's First Grade Promise, and it deserves more attention than another polished education announcement usually gets. At a Nov. 5 Convene 2026 gathering in Boston, 56 district and literacy leaders from six states focused on getting children reading...

Continue Reading

Top 5 Most Recently Viewed Articles

Nabors Industries Expands Reach with Parker Wellbore Buyout

Updated Category News Views 205

Nabors Industries Completes Acquisition of Parker Wellbore Nabors Industries Ltd. (NYSE: NBR) has officially concluded its acquisition of Parker Wellbore, a strategic move that strengthens Nabors' leadership in drilling and associated value-added services. This acquisition not only cements Nabors' robust market position but also enhances its service capabilities across...

Continue Reading
Utz, Integer, Arcosa, Dominion: Fair Deals for Shareholders?

Updated Category News Views 18

Investor Concerns Over Recent M&A Deals Today, you can't shake a stick without hitting some M&A news and, frankly, these deals with Utz, Integer, Arcosa, and Dominion have got investors squirming in their seats. With insiders possibly raking in the dough, shareholders are left wondering if they’re just getting table scraps. And you know what makes folks justifiably...

Continue Reading
Revolutionizing Business Growth with QuickBooks AI Tools

Updated Category News Views 151

Revolutionizing Business Growth with QuickBooks AI Tools Software Experts recently spotlighted QuickBooks for its innovative approach in transforming business financial forecasting and planning. The introduction of AI-driven agents in QuickBooks signifies a major transition towards more connected and automated financial management, streamlining processes while enhancing...

Continue Reading
CMB Certification: A New Era for Sustainable Wellness Brands

Updated Category News Views 234

CMB Certification: Pioneering a Path for Wellness Brands Crunchy Mama Box (CMB) has recently unveiled its CMB Certification Program, an initiative that aims to validate wellness brands dedicated to sustainability, ethical practices, and social contributions. This certification serves as a valuable tool for consumers, empowering them to make well-informed decisions while...

Continue Reading
Prevounce Health Integrates AI for Enhanced Patient Care Solutions

Updated Category News Views 303

Prevounce Health Enhances Remote Care with Innovative AI Insights Prevounce Health has recently unveiled an exciting feature that integrates artificial intelligence into its remote care management offerings. This initiative aims to provide AI-generated summaries and personalized recommendations for patients enrolled in remote care management programs, transforming the...

Continue Reading